BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31627410)

  • 1. Prediabetes/Diabetes Can Be Screened at the Dental Office by a Low-Cost and Fast Chair-Side/Point-of-Care aMMP-8 Immunotest.
    Grigoriadis A; Sorsa T; Räisänen I; Pärnänen P; Tervahartiala T; Sakellari D
    Diagnostics (Basel); 2019 Oct; 9(4):. PubMed ID: 31627410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediabetes/diabetes screening strategy at the periodontal clinic.
    Grigoriadis A; Räisänen IT; Pärnänen P; Tervahartiala T; Sorsa T; Sakellari D
    Clin Exp Dent Res; 2021 Feb; 7(1):85-92. PubMed ID: 33300692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of active matrix metalloproteinase-8 (aMMP-8) chair-side test as a diagnostic biomarker in the staging of periodontal diseases.
    Öztürk VÖ; Emingil G; Umeizudike K; Tervahartiala T; Gieselmann DR; Maier K; Köse T; Sorsa T; Alassiri S
    Arch Oral Biol; 2021 Apr; 124():104955. PubMed ID: 33556789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active MMP-8 point-of-care (PoC)/chairside enzyme-test as an adjunctive tool for early and real-time diagnosis of peri-implantitis.
    Lähteenmäki H; Tervahartiala T; Räisänen IT; Pärnänen P; Mauramo M; Gupta S; Sampson V; Rathnayake N; Heikkinen AM; Alassiri S; Gieselmann DR; Frankenberger R; Sorsa T
    Clin Exp Dent Res; 2022 Apr; 8(2):485-496. PubMed ID: 35118828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral active matrix metalloproteinase-8 immunotest may be less accurate in haemato-oncologic patients.
    Mauramo M; Uutela P; Sorsa T; Tervahartiala T; Bornstein MM; Waltimo T
    Oral Dis; 2024 Mar; 30(2):624-630. PubMed ID: 35925017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a novel point-of-care test for active matrix metalloproteinase-8: agreement between qualitative and quantitative measurements and relation to periodontal inflammation.
    Lorenz K; Keller T; Noack B; Freitag A; Netuschil L; Hoffmann T
    J Periodontal Res; 2017 Apr; 52(2):277-284. PubMed ID: 27214099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An aMMP-8 Point-of-Care and Questionnaire Based Real-Time Diagnostic Toolkit for Medical Practitioners.
    Räisänen IT; Lähteenmäki H; Gupta S; Grigoriadis A; Sahni V; Suojanen J; Seppänen H; Tervahartiala T; Sakellari D; Sorsa T
    Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33921148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic.
    Sorsa T; Sahni V; Buduneli N; Gupta S; Räisänen IT; Golub LM; Lee HM; Pätilä T; Bostanci N; Meurman J; Pärnänen P; Nwhator SO; Singla M; Gauba K
    Expert Rev Proteomics; 2021 Aug; 18(8):707-717. PubMed ID: 34468272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of chairside salivary aMMP-8 findings with periodontal risk assessment parameters in patients receiving supportive periodontal therapy.
    Schmalz G; Kummer MK; Kottmann T; Rinke S; Haak R; Krause F; Schmidt J; Ziebolz D
    J Periodontal Implant Sci; 2018 Aug; 48(4):251-260. PubMed ID: 30202608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Oral Rinse Active Matrix Metalloproteinase-8 Point-of-Care Immunotest May Be Less Accurate in Patients with Crohn's Disease.
    Rautava J; Gürsoy UK; Kullström A; Könönen E; Sorsa T; Tervahartiala T; Gürsoy M
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32143418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases.
    Sorsa T; Nwhator SO; Sakellari D; Grigoriadis A; Umeizudike KA; Brandt E; Keskin M; Tervahartiala T; Pärnänen P; Gupta S; Mohindra R; Bostanci N; Buduneli N; Räisänen IT
    Front Oral Health; 2022; 3():897115. PubMed ID: 35757444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of active matrix metalloproteinase-8 point-of-care test for the discrimination of periodontal health status: Comparison of saliva and oral rinse samples.
    Deng K; Wei S; Xu M; Shi J; Lai H; Tonetti MS
    J Periodontal Res; 2022 Aug; 57(4):768-779. PubMed ID: 35575900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between serum and oral matrix metalloproteinase-8 levels and periodontal health status.
    Noack B; Kipping T; Tervahartiala T; Sorsa T; Hoffmann T; Lorenz K
    J Periodontal Res; 2017 Oct; 52(5):824-831. PubMed ID: 28345244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of a point-of-care aMMP-8 test in the discrimination of periodontal health and disease.
    Deng K; Pelekos G; Jin L; Tonetti MS
    J Clin Periodontol; 2021 Aug; 48(8):1051-1065. PubMed ID: 33998040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active Matrix Metalloproteinase-8 Point-of-Care (PoC)/Chairside Mouthrinse Test vs. Bleeding on Probing in Diagnosing Subclinical Periodontitis in Adolescents.
    Räisänen IT; Sorsa T; van der Schoor GJ; Tervahartiala T; van der Schoor P; Gieselmann DR; Heikkinen AM
    Diagnostics (Basel); 2019 Mar; 9(1):. PubMed ID: 30909530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-Care/Chairside aMMP-8 Analytics of Periodontal Diseases' Activity and Episodic Progression.
    Räisänen IT; Heikkinen AM; Siren E; Tervahartiala T; Gieselmann DR; van der Schoor GJ; van der Schoor P; Sorsa T
    Diagnostics (Basel); 2018 Oct; 8(4):. PubMed ID: 30360358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active Matrix Metalloproteinase-8 (aMMP-8) Versus Total MMP-8 in Periodontal and Peri-Implant Disease Point-of-Care Diagnostics.
    Räisänen IT; Aji NRAS; Sakellari D; Grigoriadis A; Rantala I; Pätilä T; Heikkilä P; Gupta S; Sorsa T
    Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between different protein species of oral rinse MMP-8 and patient-related factors.
    Leppilahti JM; Tervahartiala T; Kautiainen H; Räisänen I; Ahonen MM; Uitto VJ; Sorsa T; Mäntylä P
    Clin Exp Dent Res; 2023 Dec; 9(6):1021-1033. PubMed ID: 37877535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a noninvasive aMMP-8 point-of-care diagnostic methodology in COVID-19 patients with periodontal disease.
    Gupta S; Mohindra R; Singla M; Khera S; Kumar A; Rathnayake N; Sorsa T; Pfützner A; Räisänen IT; Soni RK; Kanta P; Jain A; Gauba K; Goyal K; Singh MP; Ghosh A; Kajal K; Mahajan V; Suri V; Bhalla A
    Clin Exp Dent Res; 2022 Aug; 8(4):988-1001. PubMed ID: 35818743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ability of Quantitative, Specific, and Sensitive Point-of-Care/Chair-Side Oral Fluid Immunotests for aMMP-8 to Detect Periodontal and Peri-Implant Diseases.
    Alassiri S; Parnanen P; Rathnayake N; Johannsen G; Heikkinen AM; Lazzara R; van der Schoor P; van der Schoor JG; Tervahartiala T; Gieselmann D; Sorsa T
    Dis Markers; 2018; 2018():1306396. PubMed ID: 30154936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.